Chapter 12 Modulation of the Cys-Loop Ligand-Gated Ion Channels by Fatty Acid and Cannabinoids

Vitamins and Hormones

Volumn 81, Issue C, 2009, Pages 315-335

  Zhang, Li ^a   Xiong, Wei ^a  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; CANNABINOID; CANNABINOID RECEPTOR; CHOLINERGIC RECEPTOR; CHOLINERGIC RECEPTOR BLOCKING AGENT; ENDOCANNABINOID; FATTY ACID; GLYCINE RECEPTOR; ION CHANNEL; SEROTONIN 3 RECEPTOR;

ANIMAL; CHANNEL GATING; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; PHYSIOLOGY; REVIEW;

ANIMALS; CANNABINOIDS; CHOLINERGIC ANTAGONISTS; ENDOCANNABINOIDS; FATTY ACIDS; HUMANS; ION CHANNEL GATING; ION CHANNELS; RECEPTORS, CANNABINOID; RECEPTORS, CHOLINERGIC; RECEPTORS, GABA-A; RECEPTORS, GLYCINE; RECEPTORS, SEROTONIN, 5-HT3;

EID: 67651166647     PISSN: 00836729     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0083-6729(09)81012-1     Document Type: Review

References (80)

1. Barann M., Molderings G., Bruss M., Bonisch H., Urban B.W., and Gothert M. Direct inhibition by cannabinoids of human 5-HT3A receptors: Probable involvement of an allosteric modulatory site. Br. J. Pharmacol. 137 5 (2002) 589-596
2. Barrera N.P., Herbert P., Henderson R.M., Martin I.L., and Edwardson J.M. Atomic force microscopy reveals the stoichiometry and subunit arrangement of 5-HT3 receptors. Proc. Natl. Acad. Sci. USA 102 35 (2005) 12595-12600
3. Bradaia A., Schlichter R., and Trouslard J. Role of glial and neuronal glycine transporters in the control of glycinergic and glutamatergic synaptic transmission in lamina X of the rat spinal cord. J. Physiol. 559 Pt. 1 (2004) 169-186
4. Butt C., Alptekin A., Shippenberg T., and Oz M. Endogenous cannabinoid anandamide inhibits nicotinic acetylcholine receptor function in mouse thalamic synaptosomes. J. Neurochem. 105 4 (2008) 1235-1243
5. Changeux J.P., Bertrand D., Corringer P.J., Dehaene S., Edelstein S., Lena C., Le Novere N., Marubio L., Picciotto M., and Zoli M. Brain nicotinic receptors: Structure and regulation, role in learning and reinforcement. Brain Res. Brain Res. Rev. 26 2-3 (1998) 198-216
6. Corringer P.J., Le Novere N., and Changeux J.P. Nicotinic receptors at the amino acid level. Annu. Rev. Pharmacol. Toxicol. 40 (2000) 431-458
7. Dani J.A., and Bertrand D. Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system. Annu. Rev. Pharmacol. Toxicol. 47 (2007) 699-729
8. DelRaso N.J., Huang Y., and Lu L. Effects of chlorotrifluoroethylene oligomer fatty acids on recombinant GABA receptors expressed in Xenopus oocytes. J. Membr. Biol. 149 1 (1996) 33-40
9. Diana M.A., and Bregestovski P. Calcium and endocannabinoids in the modulation of inhibitory synaptic transmission. Cell Calcium 37 5 (2005) 497-505
10. Di Marzo V., Breivogel C.S., Tao Q., Bridgen D.T., Razdan R.K., Zimmer A.M., Zimmer A., and Martin B.R. Levels, metabolism, and pharmacological activity of anandamide in CB(1) cannabinoid receptor knockout mice: Evidence for non-CB(1), non-CB(2) receptor-mediated actions of anandamide in mouse brain. J. Neurochem. 75 6 (2000) 2434-2444
11. Eulenburg V., Armsen W., Betz H., and Gomeza J. Glycine transporters: Essential regulators of neurotransmission. Trends Biochem. Sci. 30 6 (2005) 325-333
12. Fan P. Cannabinoid agonists inhibit the activation of 5-HT3 receptors in rat nodose ganglion neurons. J. Neurophysiol. 73 2 (1995) 907-910
13. Frank B., Niesler B., Nothen M.M., Neidt H., Propping P., Bondy B., Rietschel M., Maier W., Albus M., and Rappold G. Investigation of the human serotonin receptor gene HTR3B in bipolar affective and schizophrenic patients. Am. J. Med. Genet. B Neuropsychiatr. Genet. 131B 1 (2004) 1-5
14. Gaddum J.H., and Hameed K.A. Drugs which antagonize 5-hydroxytryptamine. Br. J. Pharmacol. Chemother. 9 2 (1954) 240-248
15. Gerdeman G.L., Ronesi J., and Lovinger D.M. Postsynaptic endocannabinoid release is critical to long-term depression in the striatum. Nat. Neurosci. 5 5 (2002) 446-451
16. Godlewski G., Gothert M., and Malinowska B. Cannabinoid receptor-independent inhibition by cannabinoid agonists of the peripheral 5-HT3 receptor-mediated von Bezold-Jarisch reflex. Br. J. Pharmacol. 138 5 (2003) 767-774
17. Gomeza J., Hulsmann S., Ohno K., Eulenburg V., Szoke K., Richter D., and Betz H. Inactivation of the glycine transporter 1 gene discloses vital role of glial glycine uptake in glycinergic inhibition. Neuron 40 4 (2003) 785-796
18. Grant K.A. The role of 5-HT3 receptors in drug dependence. Drug Alcohol Depend. 38 2 (1995) 155-171
19. Hamano H., Nabekura J., Nishikawa M., and Ogawa T. Docosahexaenoic acid reduces GABA response in substantia nigra neuron of rat. J. Neurophysiol. 75 3 (1996) 1264-1270
20. Hejazi N., Zhou C., Oz M., Sun H., Ye J.H., and Zhang L. {Delta}9-tetrahydrocannabinol and endogenous cannabinoid anandamide directly potentiate the function of glycine receptors. Mol. Pharmacol. 69 3 (2006) 991-997
21. Hogg R.C., Raggenbass M., and Bertrand D. Nicotinic acetylcholine receptors: From structure to brain function. Rev. Physiol. Biochem. Pharmacol. 147 (2003) 1-46
22. Howlett A.C., Barth F., Bonner T.I., Cabral G., Casellas P., Devane W.A., Felder C.C., Herkenham M., Mackie K., Martin B.R., Mechoulam R., and Pertwee R.G. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol. Rev. 54 2 (2002) 161-202
23. Huang J., Spier A.D., and Pickel V.M. 5-HT3A receptor subunits in the rat medial nucleus of the solitary tract: Subcellular distribution and relation to the serotonin transporter. Brain Res. 1028 2 (2004) 156-169
24. Huestis M.A., and Cone E.J. Relationship of Delta 9-tetrahydrocannabinol concentrations in oral fluid and plasma after controlled administration of smoked cannabis. J. Anal. Toxicol. 28 6 (2004) 394-399
25. Iatsenko N.M., Tsintsadze T., and Lozova N.O. The synthetic cannabinoid analog WIN 55,212-2 potentiates the amplitudes of glycine-activated currents. Fiziol. Zh. 53 3 (2007) 31-37
26. Kelley S.P., Dunlop J.I., Kirkness E.F., Lambert J.J., and Peters J.A. A cytoplasmic region determines single-channel conductance in 5-HT3 receptors. Nature 424 6946 (2003) 321-324
27. Koenig J.A., and Martin I.L. Effect of free fatty acids on GABAA receptor ligand binding. Biochem. Pharmacol. 44 1 (1992) 11-15
28. Lagalwar S., Bordayo E.Z., Hoffmann K.L., Fawcett J.R., and Frey II W.H. Anandamides inhibit binding to the muscarinic acetylcholine receptor. J. Mol. Neurosci. 13 1-2 (1999) 55-61
29. Lena C., and Changeux J.P. Pathological mutations of nicotinic receptors and nicotine-based therapies for brain disorders. Curr. Opin. Neurobiol. 7 5 (1997) 674-682
30. Lindstrom J., Anand R., Gerzanich V., Peng X., Wang F., and Wells G. Structure and function of neuronal nicotinic acetylcholine receptors. Prog. Brain Res. 109 (1996) 125-137
31. Lozovaya N., Yatsenko N., Beketov A., Tsintsadze T., and Burnashev N. Glycine receptors in CNS neurons as a target for nonretrograde action of cannabinoids. J. Neurosci. 25 33 (2005) 7499-7506
32. Lynch J.W. Molecular structure and function of the glycine receptor chloride channel. Physiol. Rev. 84 4 (2004) 1051-1095
33. Lynch J.W. Native glycine receptor subtypes and their physiological roles. Neuropharmacology 56 1 (2009) 303-309
34. Lynch J.W., and Callister R.J. Glycine receptors: A new therapeutic target in pain pathways. Curr. Opin. Investig. Drugs 7 1 (2006) 48-53
35. Macdonald R.L., and Olsen R.W. GABAA receptor channels. Annu. Rev. Neurosci. 17 (1994) 569-602
36. Maricq A.V., Peterson A.S., Brake A.J., Myers R.M., and Julius D. Primary structure and functional expression of the 5HT3 receptor, a serotonin-gated ion channel. Science 254 5030 (1991) 432-437
37. Miyazawa A., Fujiyoshi Y., and Unwin N. Structure and gating mechanism of the acetylcholine receptor pore. Nature 423 6943 (2003) 949-955
38. Molander A., and Soderpalm B. Accumbal strychnine-sensitive glycine receptors: An access point for ethanol to the brain reward system. Alcohol. Clin. Exp. Res. 29 1 (2005) 27-37
39. Molander A., and Soderpalm B. Glycine receptors regulate dopamine release in the rat nucleus accumbens. Alcohol. Clin. Exp. Res. 29 1 (2005) 17-26
40. Morales M., Battenberg E., and Bloom F.E. Distribution of neurons expressing immunoreactivity for the 5HT3 receptor subtype in the rat brain and spinal cord. J. Comp. Neurol. 402 3 (1998) 385-401
41. Morales M., Wang S.D., Diaz-Ruiz O., and Jho D.H. Cannabinoid CB1 receptor and serotonin 3 receptor subunit A (5-HT3A) are co-expressed in GABA neurons in the rat telencephalon. J. Comp. Neurol. 468 2 (2004) 205-216
42. Nabekura J., Noguchi K., Witt M.R., Nielsen M., and Akaike N. Functional modulation of human recombinant gamma-aminobutyric acid type A receptor by docosahexaenoic acid. J. Biol. Chem. 273 18 (1998) 11056-11061
43. Nielsen M., Witt M.R., and Thogersen H. [3H]diazepam specific binding to rat cortex in vitro is enhanced by oleic, arachidonic and docosahexenoic acid isolated from pig brain. Eur. J. Pharmacol. 146 2-3 (1988) 349-353
44. 2+/calmodulin-dependent protein kinase II. Neuroreport 8 3 (1997) 597-601
45. Nishizaki T., Ikeuchi Y., Matsuoka T., and Sumikawa K. Short-term depression and long-term enhancement of ACh-gated channel currents induced by linoleic and linolenic acid. Brain Res. 751 2 (1997) 253-258
46. Nishizaki T., Nomura T., Matsuoka T., Enikolopov G., and Sumikawa K. Arachidonic acid induces a long-lasting facilitation of hippocampal synaptic transmission by modulating PKC activity and nicotinic ACh receptors. Brain Res. Mol. Brain Res. 69 2 (1999) 263-272
47. Olsen R.W., and Tobin A.J. Molecular biology of GABAA receptors. FASEB J. 4 5 (1990) 1469-1480
48. Oz M. Receptor-independent actions of cannabinoids on cell membranes: Focus on endocannabinoids. Pharmacol. Ther. 111 1 (2006) 114-144
49. Oz M., Zhang L., and Morales M. Endogenous cannabinoid, anandamide, acts as a noncompetitive inhibitor on 5-HT3 receptor-mediated responses in Xenopus oocytes. Synapse 46 3 (2002) 150-156
50. Oz M., Ravindran A., Diaz-Ruiz O., Zhang L., and Morales M. The endogenous cannabinoid anandamide inhibits alpha7 nicotinic acetylcholine receptor-mediated responses in Xenopus oocytes. J. Pharmacol. Exp. Ther. 306 3 (2003) 1003-1010
51. Oz M., Zhang L., Ravindran A., Morales M., and Lupica C.R. Differential effects of endogenous and synthetic cannabinoids on alpha7-nicotinic acetylcholine receptor-mediated responses in Xenopus oocytes. J. Pharmacol. Exp. Ther. 310 3 (2004) 1152-1160
52. Pacher P., Batkai S., and Kunos G. The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol. Rev. 58 3 (2006) 389-462
53. Pertwee R.G. Pharmacological actions of cannabinoids. Handb. Exp. Pharmacol. 168 (2005) 1-51
54. Peters J.A., Kelley S.P., Dunlop J.I., Kirkness E.F., Hales T.G., and Lambert J.J. The 5-hydroxytryptamine type 3 (5-HT3) receptor reveals a novel determinant of single-channel conductance. Biochem. Soc. Trans. 32 Pt. 3 (2004) 547-552
55. Peters J.A., Hales T.G., and Lambert J.J. Molecular determinants of single-channel conductance and ion selectivity in the Cys-loop family: Insights from the 5-HT3 receptor. Trends Pharmacol. Sci. 26 11 (2005) 587-594
56. Przegalinski E., Gothert M., Frankowska M., and Filip M. WIN 55,212-2-induced reduction of cocaine hyperlocomotion: Possible inhibition of 5-HT(3) receptor function. Eur. J. Pharmacol. 517 1-2 (2005) 68-73
57. Samochocki M., and Strosznajder J. Modulatory action of arachidonic acid on GABAA/chloride channel receptor function in adult and aged brain cortex membranes. Neurochem. Int. 23 3 (1993) 261-267
58. Saxena N.C. Inhibition of GABA(A) receptor (GABAR) currents by arachidonic acid in HEK 293 cells stably transfected with alpha1beta2gamma2 GABAR subunits. Pflugers Arch. 440 3 (2000) 380-392
59. Schwartz R.D., and Yu X. Inhibition of GABA-gated chloride channel function by arachidonic acid. Brain Res. 585 1-2 (1992) 405-410
60. Sieghart W. Structure, pharmacology, and function of GABAA receptor subtypes. Adv. Pharmacol. 54 (2006) 231-263
61. Spivak C.E., Lupica C.R., and Oz M. The endocannabinoid anandamide inhibits the function of alpha4beta2 nicotinic acetylcholine receptors. Mol. Pharmacol. 72 4 (2007) 1024-1032
62. Sun H., Hu X.Q., Emerit M.B., Schoenebeck J.C., Kimmel C.E., Peoples R.W., Miko A., and Zhang L. Modulation of 5-HT3 receptor desensitization by the light chain of microtubule-associated protein 1B expressed in HEK 293 cells. J. Physiol. 586 3 (2008) 751-762
63. Tecott L.H., Maricq A.V., and Julius D. Nervous system distribution of the serotonin 5-HT3 receptor mRNA. Proc. Natl. Acad. Sci. USA 90 4 (1993) 1430-1434
64. Thompson A.J., Zhang L., and Lummis S.R. 5-HT3 Receptors. (2006), Humana Press, Totowa, NJ
65. Unwin N. Nicotinic acetylcholine receptor at 9 A resolution. J. Mol. Biol. 229 4 (1993) 1101-1124
66. van der Stelt M., and Di Marzo V. Anandamide as an intracellular messenger regulating ion channel activity. Prostaglandins Other Lipid Mediat. 77 1-4 (2005) 111-122
67. van Hooft J.A., and Vijverberg H.P. 5-HT(3) receptors and neurotransmitter release in the CNS: A nerve ending story?. Trends Neurosci. 23 12 (2000) 605-610
68. Vijayaraghavan S., Huang B., Blumenthal E.M., and Berg D.K. Arachidonic acid as a possible negative feedback inhibitor of nicotinic acetylcholine receptors on neurons. J. Neurosci. 15 5 Pt. 1 (1995) 3679-3687
69. Waeber C., Dixon K., Hoyer D., and Palacios J.M. Localisation by autoradiography of neuronal 5-HT3 receptors in the mouse CNS. Eur. J. Pharmacol. 151 2 (1988) 351-352
70. Waeber C., Hoyer D., and Palacios J.M. 5-hydroxytryptamine3 receptors in the human brain: Autoradiographic visualization using [3H]ICS 205-930. Neuroscience 31 2 (1989) 393-400
71. Waeber C., Pinkus L.M., and Palacios J.M. The (S)-isomer of [3H]zacopride labels 5-HT3 receptors with high affinity in rat brain. Eur. J. Pharmacol. 181 3 (1990) 283-287
72. Whitehead K.J., Manning J.P., Smith C.G., and Bowery N.G. Determination of the extracellular concentration of glycine in the rat spinal cord dorsal horn by quantitative microdialysis. Brain Res. 910 1-2 (2001) 192-194
73. Wilson R.I., and Nicoll R.A. Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature 410 6828 (2001) 588-592
74. Witt M.R., and Nielsen M. Characterization of the influence of unsaturated free fatty acids on brain GABA/benzodiazepine receptor binding in vitro. J. Neurochem. 62 4 (1994) 1432-1439
75. Witt M.R., Westh-Hansen S.E., Rasmussen P.B., Hastrup S., and Nielsen M. Unsaturated free fatty acids increase benzodiazepine receptor agonist binding depending on the subunit composition of the GABAA receptor complex. J. Neurochem. 67 5 (1996) 2141-2145
76. Xiong W., Hosoi M., Koo B.N., and Zhang L. Anandamide inhibition of 5-HT3A receptors varies with receptor density and desensitization. Mol. Pharmacol. 73 2 (2008) 314-322
77. Yakel J.L., and Jackson M.B. 5-HT3 receptors mediate rapid responses in cultured hippocampus and a clonal cell line. Neuron 1 7 (1988) 615-621
78. Yang Z., Aubrey K.R., Alroy I., Harvey R.J., Vandenberg R.J., and Lynch J.W. Subunit-specific modulation of glycine receptors by cannabinoids and N-arachidonyl-glycine. Biochem. Pharmacol. 76 8 (2008) 1014-1023
79. Zhang L., and Lummis S.C. 5-HT3 Receptors (2006), Marcel Dekker, New York 6
80. Zimmer A., Zimmer A.M., Hohmann A.G., Herkenham M., and Bonner T.I. Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. Proc. Natl. Acad. Sci. USA 96 10 (1999) 5780-5785